abstract |
The present invention relates to a prophylactic or therapeutic agent for glomerular disease comprising an antiplatelet agent and an HMG-CoA reductase inhibitor as an active ingredient. This agent is useful for the prevention or treatment of various glomerular diseases, including chronic glomerulonephritis. |